Testing treat-to-target outcomes with initial methotrexate monotherapy compared with initial tumour necrosis factor inhibitor (adalimumab) plus methotrexate in early rheumatoid arthritis

類似資料

• Achieving comprehensive disease control in patients with early and established rheumatoid arthritis treated with adalimumab plus methotrexate versus methotrexate alone
  著者:: Keystone, Edward C, 等
  出版事項: (2017)
• Long-term use of adalimumab as monotherapy after attainment of low disease activity with adalimumab plus methotrexate in patients with rheumatoid arthritis
  著者:: Keystone, Edward C, 等
  出版事項: (2018)
• Clinical, functional and radiographic consequences of achieving stable low disease activity and remission with adalimumab plus methotrexate or methotrexate alone in early rheumatoid arthritis: 26-week results from the randomised, controlled OPTIMA study
  著者:: Kavanaugh, Arthur, 等
  出版事項: (2013)
• Predictors of disease activity and structural progression after treatment with adalimumab plus methotrexate or continued methotrexate monotherapy in patients with early rheumatoid arthritis and suboptimal response to methotrexate
  著者:: Smolen, Josef S, 等
  出版事項: (2018)
• Efficacy and safety of ascending methotrexate dose in combination with adalimumab: the randomised CONCERTO trial
  著者:: Burmester, Gerd-Rűdiger, 等
  出版事項: (2015)